Axsome Therapeutics Inc
SWB:19X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Axsome Therapeutics Inc
SWB:19X
|
US |
|
C
|
CapitaLand Integrated Commercial Trust
XMUN:M3T
|
SG |
|
C
|
Clean Harbors Inc
SWB:CH6
|
US |
|
M
|
Macerich Co
F:M6G
|
US |
|
E
|
Elisa Oyj
F:EIA
|
FI |
|
R
|
Radian Group Inc
SWB:RAG
|
US |
|
F
|
Fairfax Financial Holdings Ltd
BMV:FFHN
|
CA |
|
Energy of Minas Gerais Co
F:CIDS
|
BR |
Wall St Price Targets
19X Price Targets Summary
Axsome Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 19X is 237.11 EUR with a low forecast of 175.64 EUR and a high forecast of 283.02 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 19X's stock price target?
Price Target
237.11
EUR
According to Wall Street analysts, the average 1-year price target for 19X is 237.11 EUR with a low forecast of 175.64 EUR and a high forecast of 283.02 EUR.
What is the Revenue forecast for Axsome Therapeutics Inc?
Projected CAGR
55%
The compound annual growth rate for Revenue over the next 3 years is 55%.
What is the Gross Profit forecast for Axsome Therapeutics Inc?
Projected CAGR
51%
The compound annual growth rate for Gross Profit over the next 3 years is 51%.
